[HTML][HTML] Machine learning approaches to genome-wide association studies

DO Enoma, J Bishung, T Abiodun, O Ogunlana… - Journal of King Saud …, 2022 - Elsevier
Abstract Genome-wide Association Studies (GWAS) are conducted to identify single
nucleotide polymorphisms (variants) associated with a phenotype within a specific …

Pharmacogenetic Panel Testing: A Review of Current Practice and Potential for Clinical Implementation

R Mosch, M van der Lee, HJ Guchelaar… - Annual Review of …, 2025 - annualreviews.org
Pharmacogenetics (PGx) aims to optimize drug treatment outcomes by using a patient's
genetic profile for individualized drug and dose selection. Currently, reactive and …

Analytical validation of GenoPharm a clinical genotyping open array panel of 46 pharmacogenes inclusive of variants unique to people of African ancestry

CR Kanji, BT Mbavha, C Masimirembwa… - Plos one, 2023 - journals.plos.org
Pharmacogenomic testing may be used to improve treatment outcomes and reduce the
frequency of adverse drug reactions (ADRs). Population specific, targeted …

Population genetic polymorphisms of pharmacogenes in Zimbabwe, a potential guide for the safe and efficacious use of medicines in people of African ancestry

BT Mbavha, CR Kanji, N Stadler, J Stingl… - Pharmacogenetics …, 2022 - journals.lww.com
Objective Pharmacogenomics (PGx) is a clinically significant factor in the safe and
efficacious use of medicines. While PGx knowledge is abundant for other populations, there …

The extent and impact of variation in ADME genes in sub-Saharan African populations

JEB Da Rocha, H Othman, G Botha, L Cottino… - Frontiers in …, 2021 - frontiersin.org
Introduction: Investigating variation in genes involved in the absorption, distribution,
metabolism, and excretion (ADME) of drugs are key to characterizing pharmacogenomic …

AI can help to tailor drugs for Africa—but Africans should lead the way

G Turon, M Njoroge, M Mulubwa, M Duran-Frigola… - Nature, 2024 - nature.com
Computational models that require very little data could transform biomedical and drug
development research in Africa, as long as infrastructure, trained staff and secure databases …

[HTML][HTML] Allostery and missense mutations as intermittently linked promising aspects of modern computational drug discovery

ÖT Bishop, TM Musyoka, V Barozi - Journal of Molecular Biology, 2022 - Elsevier
Drug research and development is a multidisciplinary field with its own successes. Yet,
given the complexity of the process, it also faces challenges over the long development …

The role of pharmacogenomics studies for precision medicine among Ethiopian patients and their clinical implications: a scoping review

KA Getahun, DA Angaw, MS Asres… - Pharmacogenomics …, 2024 - Taylor & Francis
Background Pharmacogenomics research is currently revolutionizing treatment optimization
by discovering molecular markers. Medicines are the cornerstone of treatment for both acute …

Promoting Pharmacogenomics in Africa: Perspectives From Variation in G6PD and Other Pharmacogenes.

BR Sitabule, H Othman, A Choudhury… - Clinical …, 2023 - search.ebscohost.com
African pharmacogenomics consortium: consolidating pharmacogenomics knowledge,
capacity development and translation in Africa: consolidating pharmacogenomics …

From Drug Discovery to Drug Approval: A Comprehensive Review of the Pharmacogenomics Status Quo with a Special Focus on Egypt

FM Elgarhy, A Borham, N Alziny, KR AbdElaal… - …, 2024 - pmc.ncbi.nlm.nih.gov
Pharmacogenomics (PGx) is the hope for the full optimization of drug therapy while
minimizing the accompanying adverse drug events that cost billions of dollars annually …